Filing Details
- Accession Number:
- 0001127602-14-004516
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-05 08:05:18
- Reporting Period:
- 2014-02-03
- Filing Date:
- 2014-02-05
- Accepted Time:
- 2014-02-05 08:05:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
799729 | Parexel International Corp | PRXL | Services-Commercial Physical & Biological Research (8731) | 042776269 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1278042 | A Mark Goldberg | Parexel International Corporation 195 West Street Waltham MA 02451 | President & Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2014-02-03 | 13,029 | $48.68 | 105,588 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-02-03 | 500 | $49.21 | 105,088 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- This transaction was executed in multiple trades through a trade order executed by a broker-dealer at prices ranging from $48.17- $49.17. The price reported in this column reflects the weighted average sale price. For all transactions reported on this Form 4 utilizing a weighted average sale price, the reporting person will provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each price.
- The reported sale was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the reporting person.
- This transaction was executed in multiple trades through a trade order executed by a broker-dealer at prices ranging from $49.18- $49.24. The price reported in this column reflects the weighted average sale price. For all transactions reported on this Form 4 utilizing a weighted average sale price, the reporting person will provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each price.